Skip to main content
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. — Investor Relations & Filings

Ticker · OVID ISIN · US6904691010 LEI · 549300H36NUI4L6U8F17 US Manufacturing
Open in API
Filings indexed 497 across all filing types
Latest filing 2023-04-26 Proxy Solicitation & In…
Country US United States of America
Listing US OVID

About Ovid Therapeutics Inc.

https://ovidrx.com/

Ovid Therapeutics Inc. is a biopharmaceutical company that develops targeted small molecule therapies for neurological conditions. The company's primary focus is on conquering epilepsies and other brain disorders by creating treatments that aim to reduce seizures and offer improved safety and tolerability. Ovid's scientific approach involves pioneering compounds with unique or potentially best-in-class mechanisms of action to address significant unmet medical needs. The company's mission is to develop medicines that improve the lives of patients and families affected by these conditions.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes details about the upcoming Annual Meeting of stockholders, voting items such as election of directors, advisory approval of executive compensation, and ratification of the independent auditor. The document is titled 'Definitive Additional Materials' related to the proxy statement and provides instructions for voting. It does not contain the full proxy statement itself but additional materials related to it. Given the nature of the document as proxy solicitation materials and voting information, the appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters and it is not the full proxy statement but additional materials, which fits the PSI category rather than the full DEF 14A or other categories.
2023-04-26 English
10-K
Annual Report FY 2022
2023-03-13 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 13, 2023, by Ovid Therapeutics Inc. It announces the issuance of a press release regarding a business update and the fourth quarter and full year 2022 financial results. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release as Exhibit 99.1. The length of the document is 3659 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than the earnings release itself. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing the release of financial results but does not contain the full financial report or detailed data. It is not the earnings release (ER) itself, nor is it a full annual or quarterly report. Therefore, the appropriate classification is RNS with high confidence.
2023-03-13 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content specifically includes a Regulation FD Disclosure about the company's relationship with Silicon Valley Bank. The document is relatively short (3299 characters) and does not contain financial statements or detailed financial data. It is an announcement of a specific event or disclosure rather than a full financial report or earnings release. Form 8-K filings are generally considered Regulatory Filings (RNS) as they cover miscellaneous regulatory announcements and disclosures that do not fit into other specific categories.
2023-03-10 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-27 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-27 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.